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Apoptosis has been shown to be a signi cant form of cell loss in
many diseases. Detachment of photoreceptors from the retinal
pigmentepithelium,asseeninvariousretinaldisorders,causespho-
toreceptor loss and subsequent vision decline. Although caspase-
dependent apoptotic pathways are activated after retinal detach-
ment, caspase inhibition by the pan-caspase inhibitor Z-VAD fails to
preventphotoreceptordeath;thus,weinvestigatedotherpathways
leading to cell loss. Here, we show that receptor interacting protein
(RIP) kinase-mediated necrosis is a signi cant mode of photorecep-
tor cell loss in an experimental model of retinal detachment and
when caspases are inhibited, RIP-mediated necrosis becomes the
predominant form of death. RIP3 expression, a key activator of
RIP1 kinase, increased more than 10-fold after retinal detachment.
Morphological assessment of detached retinas treated with Z-VAD
showed decreased apoptosis but signi cantly increased necrotic
photoreceptor death. RIP1 kinase inhibitor necrostatin-1 or Rip3 de-
 ciencysubstantiallypreventedthosenecroticchangesandreduced
oxidativestressandmitochondrialreleaseofapoptosis-inducingfac-
tor. Thus, RIP kinase-mediated programmed necrosis is a redundant
mechanism of photoreceptor death in addition to apoptosis, and
simultaneous inhibition of RIP kinases and caspases is essential for
effective neuroprotection and may be a novel therapeutic strategy
for treatment of retinal disorders.
degenerations | necroptosis
P
hotoreceptor deathandsubsequentvisualdeclineoccurswhen
the photoreceptors are separated from the underlying retinal
pigment epithelium. Physical separation of photoreceptors is seen
in various retinal disorders, including age-related macular de-
generation(1),diabeticretinopathy(2),aswellasrhegmatogenous
(i.e., caused by a break in the retina) retinal detachment (3, 4).
Althoughsurgeryiscarriedouttoreattachtheretina,onlytwo fths
of patients with rhegmatogenous retinal detachment involving the
macula,aregionessentialforcentralvision,recover20/40orbetter
visionbecauseofphotoreceptordeath(4,5).Thus,identi cationof
the mechanisms that underlie photoreceptor death is critical to
developing new treatment strategies for these diseases.
Apoptosis and necrosis are two major cell death modalities (6).
Apoptosis is a highly regulated process involving the caspase
family of cysteine proteases. In contrast, necrosis has been con-
sidered a passive, unregulated form of cell death; however, recent
evidenceindicates that somenecrosis can beinducedby regulated
signal transduction pathways such as those mediated by receptor
interacting protein (RIP) kinases, especially in conditions in
which caspases are inhibited or cannot be activated ef ciently (7,
8). Stimulation of the Fas and TNFR family of death domain
receptorsisknowntomediateapoptosisinmostcelltypesthrough
the activation of the extrinsic caspase pathway. In addition, in cer-
tain cells de cient for caspase-8 or treated with the pan-caspase
inhibitor Z-VAD, stimulation of death domain receptors causes
aRIP1kinase-dependent programmednecroticcelldeathinstead
of apoptosis (9, 10). This unique mechanism of cell death is
termed programmed necrosis or necroptosis (11).
RIP1 is a serine/threonine kinase that contains a death domain
and forms a death signaling complex with the Fas-associated
death domain and caspase-8 in response to death domain re-
ceptor stimulation (12). During death domain receptor-induced
apoptosis, RIP1 is cleaved and inactivated by caspase-8, the
process of which is prevented by caspase inhibition (13). It has
been unclear how RIP1 kinase mediates programmed necrosis,
but recent studies revealed that the expression of RIP3 and the
RIP1–RIP3 binding through the RIP homotypic interaction motif
is a prerequisite for RIP1 kinase activation, leading to reactive
oxygenspecies(ROS) productionandnecroticcell death(14–16).
In a rodent model of retinal detachment, we have shown
that TNF-  expression levels increase substantially (17) and
that caspases are activated after retinal detachment (18, 19).
However, caspase inhibition by Z-VAD fails to prevent the retinal
detachment-induced photoreceptor death (20). By using a combi-
nation of morphological, biochemical, genetic, and pharmacolog-
ical investigations, the current study demonstrates that pro-
grammed necrosis is an essential and redundant mediator of
photoreceptor death after retinal detachment. In addition, in the
presence of the pan-caspase inhibitor Z-VAD, necrosis becomes
the predominant form of photoreceptor cell loss. We further
identi ed RIP kinases as a therapeutic target to prevent photo-
receptor loss after retinal detachment.
Result
Increased Expression of RIP3 and RIP1 After Retinal Detachment.
RIP3 is a key regulator of RIP1 kinase activation (21), and its
expression level has been shown to correlate with responsiveness
toprogrammednecrosis(14).WeassessedtheexpressionofRIP3
and RIP1 mRNA in the retina 3 d after retinal detachment by
quantitative real-time PCR. This time point was chosen because
photoreceptor death peaks at 3 d after retinal detachment (20).
RIP3 expression increased 12-fold after retinal detachment com-
pared with that in untreated retina (P = 0.0003; Fig. 1A). RIP1
expression also increased twofold (P = 0.0031; Fig. 1B). Western
blot analysis con rmed that RIP3 protein expression increased
morethan10-foldafterretinaldetachment(P=0.0209;Fig.1C).In
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sensoryretina,especiallyinouternuclearlayer(ONL),afterretinal
detachment (Fig. S1). These data suggest that RIP-mediated pro-
grammed necrosis may be involved in the photoreceptor loss after
retinal detachment.
RIP1 Kinase Inhibitor Prevents Retinal Detachment-Induced Photore-
ceptorDeathonlyinCombinationwithCaspaseInhibitor.Necrostatin-1
(Nec-1)isa potentandselectiveinhibitorofprogrammednecrosis,
which targets RIP1 kinase activity (10). RIP1 is phosphorylated at
several serine residues in its kinase domain during programmed
necrosis and Nec-1 inhibits this phosphorylation (10, 15). To fur-
ther investigate the role of RIP1 kinase in retinal detachment-
inducedphotoreceptordeath,we rstassessedthephosphorylation
status of RIP1 by immunoprecipitating RIP1 from the retina (Fig.
S2A) and then blotting with anti-phosphoserine antibody. Nec-1
(400 M)and/orZ-VAD(300 M)wereinjectedsubretinallyatthe
time of retinal detachment induction. The dose of compounds was
selected based on pilot studies that established that the half-life of
the compound is approximately 6 h in the subretinal space. After
retinal detachment, RIP1 phosphorylation was elevated especially
in Z-VAD-treated retina compared with untreated retina (Fig.
S2B). Importantly, Nec-1 plus Z-VAD treatment substantially
inhibited this increase of RIP1 phosphorylation (Fig. S2B).
We next examined photoreceptor death by TUNEL 3 d after
retinal detachment. Treatment with Nec-1 or Z-VAD alone
showed no signi cant effect on the number of TUNEL-positive
cellsinONL(1,067.5±95.5cellspermm
2and1,134.7±297.5cells
permm
2,respectively)comparedwithvehicletreatment(1,366.3±
103.7 cells per mm
2; Fig. 2 A and B). In comparison, combined
treatment with Nec-1 and Z-VAD signi cantly reduced the num-
ber of TUNEL-positive cells in ONL (573.1 ± 154.3 cells per mm
2;
P<0.05;Fig.2AandB).TheappearanceofTUNEL-positivecells
was decreased to approximately 200 cells per mm
2 in each group 5
d after retinal detachment (Fig. 2B). Although detection of DNA
fragmentation by TUNEL is used as a marker of apoptosis, it has
been reported that necrosis, programmed or otherwise, also yields
DNA fragments that react with TUNEL in vivo, rendering it dif-
 culttodiscriminatebetweenapoptosisandnecrosis(22).Wenext
measured the thickness ratio of ONL to the total retinal thickness
in detached retina compared with normal attached retina. Treat-
ment with Nec-1 or Z-VAD alone had no protective effect on the
reduction of ONL thickness ratio, whereas Nec-1 plus Z-VAD
treatment signi cantly prevented the reduction in retinal thickness
3 and5 dafter retinal detachment(P < 0.05; Fig.2 A and C).More
importantly, treatment with Nec-1 plus Z-VAD showed ef cient
neuroprotection even when these compounds were injected intra-
vitreally 1 d after retinal detachment induction (P < 0.05; Fig. S3).
To further establish the speci city of RIP1 and caspase in-
hibitor, we assessed the effect of another necrostatin (Nec-4) (23)
and/or pan-caspase inhibitor (PCI) (24) on retinal detachment-
induced photoreceptor death. Nec-4 or PCI alone did not show
any neuroprotective effect, whereas Nec-4 plus PCI treatment
signi cantly suppressed photoreceptor loss after retinal de-
tachment (P < 0.05; Fig. S4). These data suggest that RIP1 kinase
is an important mediator of photoreceptor death after retinal
detachment, especially in the presence of pan-caspase inhibitor.
Caspase Inhibition Shifts Retinal Detachment-Induced Photoreceptor
Death from Apoptosis to Programmed Necrosis. We next examined
the morphology of photoreceptors after retinal detachment by
transmission EM (TEM) and analyzed the change with Nec-1 and
Z-VADtreatment.Photoreceptorsshowingcellularshrinkageand
nuclear condensation were de ned as apoptotic cells, whereas
photoreceptorsassociatedwith cellular and organelleswelling and
discontinuities in nuclear and plasma membrane were de ned as
necrotic cells. The presence of electron-dense granular materials
were reported to occur subsequent to both apoptotic and necrotic
cell death and cells with these  ndings were labeled simply as end-
stage cell death/unclassi ed (25, 26). On day 3 after retinal de-
tachment,thephotoreceptordeathcausedbyapoptosiswasalmost
twicethatcausedbynecrosisinvehicle-treatedretina(21.7±1.3%
apoptotic cells, 13.3 ± 1.0% necroticcells,4.4± 1.4% unclassi ed;
Fig. 3 A and E). Nec-1 treatment did not affect the percentage of
apoptotic and necrotic cells after retinal detachment (19.8 ± 2.0%
apoptotic cells, 13.1 ± 1.4% necroticcells,2.8± 0.4% unclassi ed;
Fig. 3 B and E). In comparison, Z-VAD treatment signi cantly
decreased apoptotic photoreceptor death and increased necrotic
cell death (11.4 ± 1.2% apoptotic cells, 21.9 ± 2.3% necrotic cells,
5.6± 1.4% unclassi ed; P < 0.05; Fig. 3 C and E). However, Nec-1
combined with Z-VAD substantially prevented the switch to
necrotic cell death and led to a decrease in both forms of cell loss
Fig. 1. Increases in RIP3 and RIP1 expression after retinal detachment.
Quantitative real-time PCR analysis for RIP3 (A)a n dR I P 1( B) in control retina
without retinal detachment and in retina 3 d after retinal detachment (n =9
each); **P < 0.01. (C) Western blot analysis for RIP3 and RIP1 after retinal
detachment (n = 4 each). Lane-loading differences were normalized by levels
of  -tubulin. For RIP3 analysis, spleen samples from WT and Rip3
 /  animals
were used as positive and negative controls, respectively. Black arrowhead
indicates RIP3; white arrowhead indicates nonspeci cb a n d .T h eb a rg r a p h s
indicate the relative level of RIP3 and RIP1 to  -tubulin by densitometric
analysis,re ectingtheresultsfromfourindependentexperiments(*P<0.05).
Fig. 2. Nec-1 combined with Z-VAD prevents photoreceptor loss after ret-
inal detachment. (A) TUNEL (green) and DAPI (blue) staining in detached
retina treated with vehicle, Nec-1, Z-VAD, or Nec-1 plus Z-VAD on day 3 after
retinal detachment. Quanti cation of TUNEL-positive photoreceptors (B)
and ONL thickness ratio (C) on day 3 (vehicle, n =1 2 ;N e c - 1 ,n =6 ;Z - V A D ,n =
12; Nec-1 plus Z-VAD, n =1 2 )a n dd a y5( v e h i c l e ,n = 8; Nec-1, n =6 ;Z - V A D ,
n =8 ;N e c - 1p l u sZ - V A D ,n = 8) after retinal detachment (*P < 0.05). GCL,
ganglion cell layer, INL, inner nuclear layer. (Scale bar, 100  m.)
21696 | www.pnas.org/cgi/doi/10.1073/pnas.1009179107 Trichonas et al.(6.9 ± 2.9% apoptotic cells, 9.8 ± 0.7% necrotic cells, 1.0 ± 0.2%
unclassi ed; P < 0.01; Fig. 3 D and E).
Consistent with the EM  ndings, subretinal injection of pro-
pidium iodide (PI) before enucleation, a technique to demon-
strate cells with disrupted cell membrane (27), showed increased
number of PI-positive photoreceptors in Z-VAD-treated retina
compared with vehicle-treated retina 3 d after retinal detachment
(P < 0.05; Fig. S5 A and B). Treatment with Nec-1 plus Z-VAD
signi cantly suppressed the number of PI-positive cells in ONL
(P < 0.05; Fig. S5 A and B).
Collectively, these data indicate that necrosis as well as apo-
ptosis is involved in photoreceptor death after retinal detachment,
and that RIP1 kinase-mediated necrosis becomes a predominant
form of the photoreceptor death when caspase-dependent apo-
ptotic pathway is inhibited.
Rip3 De ciency Inhibits Induction of Programmed Necrosis and
Prevents Photoreceptor Death After Retinal Detachment. To ana-
lyze further the role of RIP kinases in retinal detachment-induced
photoreceptor death, we caused retinal detachment in mice de-
 cient for Rip3, a key regulator of RIP1 kinase activation (21).
Without retinal detachment, the morphology of retina and ONL
thickness ratio were similar in Rip3
 /  and WT mice. Three days
after retinal detachment, Rip3
 /  mice showed signi cantly fewer
TUNEL-positive cells (804.7 ± 204.5 cells per mm
2) than WT mice
(1,668.7 ± 305.8 cells per mm
2; P < 0.01; Fig. 4 A and B). In
contrast to WT animals, Z-VAD treatment in Rip3
 /  mice further
decreased TUNEL-positive cells after retinal detachment (407.7 ±
188.9 cells per mm
2; P < 0.05 vs. Rip3
 /  mice with vehicle),
whereas Nec-1 did not provide any additional effect (786.7 ± 278.7
cells per mm
2; Fig. 4 A and B). Rip3
 /  retinas exhibited preserved
ONL thickness ratio, which was augmented by Z-VAD treatment,
on days 3 and 5 after retinal detachment (Fig. 4C).
We next performed morphological assessment of the Rip3
 / 
retina after retinal detachment by TEM. In WT mice, the per-
centage of necrotic photoreceptors was signi cantly increased by
Z-VAD treatment (13.3 ± 1.5% apoptotic cells, 22.1 ± 1.0%
necrotic cells, 1.0 ± 0.6% unclassi ed) compared with vehicle
treatment (22.2 ± 4.0% apoptotic cells, 13.0 ± 2.1% necrotic cells,
2.5 ± 1.3% unclassi ed; P < 0.05; Fig. 5 A and B). In contrast, in
Rip3
 /  mice, Z-VAD treatment substantially prevented photo-
receptor death after retinal detachment without inducing necrotic
cell death (4.8 ± 1.3% apoptotic cells, 6.4 ± 1.3% necrotic cells,
0.9 ± 0.4% unclassi ed). Consistent with these results, the number
of photoreceptors with disrupted plasma membrane, as assessed
by in vivo PI labeling, was not increased by Z-VAD treatment in
Rip3
 /  retinas (Fig. S5 C and D), con rming that RIP3 plays an
essential role to induce programmed necrosis after retinal de-
tachment, especially in the presence of caspase inhibitor. In ad-
dition, unexpectedly, Rip3
 /  retinas showed fewer apoptotic cells
after retinal detachment (13.4 ± 1.1% apoptotic cells, 8.1 ± 1.0%
necrotic cells, 1.2 ± 0.5% unclassi ed) compared with WT retinas,
suggesting that RIP3 may be involved not only in RIP1-mediated
programmed necrosis but also in other cell death pathways. Al-
ternatively, the kinetics of a single administration of Nec-1 to
inhibit RIP1 kinase are different from the chronic loss of RIP
kinase activity in Rip3
 /  animals.
As the release of intracellular content in necrosis results in
secondary in ammation, we next analyzed the in ammatory re-
action after retinal detachment by immuno uorescence detection
of the macrophage/microglial marker CD11b. On day 3 after
retinal detachment, Z-VAD-treated eyes demonstrated greater
in ltration of CD11b-positive cells in the detached retina com-
pared with vehicle-treated eyes (P < 0.05; Fig. 6 A and B), sug-
gesting that necrotic cell death may promote in ammatory
reaction. This increase of CD11b-positive cells by Z-VAD was
signi cantly suppressed with Nec-1 plus Z-VAD treatment or
Rip3 de ciency (P < 0.01; Fig. 6 A and B). We previously de-
scribed that monocyte chemoattractant protein 1 (MCP-1) is an
essential mediator of early in ltration of macrophage/microglia
and the subsequent cell death after retinal detachment (28).
However, Nec-1 plus Z-VAD did not affect MCP-1 expression
(Fig. 6C). Rip3
 /  retinas also showed substantial up-regulation of
MCP-1 after retinal detachment, although its expression level was
slightly decreased compared with WT retinas (Fig. 6D).
RIP Kinases Mediate ROS Production and Apoptosis-Inducing Factor
Nuclear Translocation After Retinal Detachment. Recent studies
reported that RIP kinases regulate downstream ROS production
during programmed necrosis (15, 16, 29). To examine the oxi-
dative retinal damage following retinal detachment, we used
ELISA for carbonyl adducts of proteins. On day 3 after retinal
Fig. 4. Rip3 de ciency provides neuroprotection after retinal detach-
ment that is augmented by Z-VAD. (A)T U N E L( g r e e n )a n dD A P I( b l u e )
staining in WT and Rip3
 /  retina treated with vehicle, Nec-1, Z-VAD, or
Nec-1 plus Z-VAD on day 3 after retinal detachment. Quanti cation of
TUNEL-positive photoreceptors (B)a n dO N Lt h i c k n e s sr a t i o( C)o nd a y3
(WT vehicle, n =6 ;Rip3
 /  vehicle, n =7 ;Rip3
 /  Nec-1, n =8 ;Rip3
 / 
Z-VAD, n =7 ;Rip3
 /  Nec-1 plus Z-VAD, n =6 )a n dd a y5( W Tv e h i c l e ,n =7 ;
Rip3
 /  vehicle, n =6 ;Rip3
 /  Nec-1, n =6 ;Rip3
 /  Z-VAD, n =6 ;Rip3
 / 
Nec-1 plus Z-VAD, n =6 )a f t e rr e t i n a ld e t a c h m e n t( * P < 0.05; **P < 0.01).
(Scale bar, 50  m.)
Fig. 3. Involvement of programmed necrosis during retinal detachment-
induced photoreceptor death. (A–D)T E Mp h o t o m i c r o g r a p h si nt h eO N Lo n
day 3 after retinal detachment in retina treated with vehicle (A), Nec-1 (B), Z-
VAD (C), or Nec-1 plus Z-VAD (D). A, apoptotic cell; N, necrotic cell. (E)
Quanti cation of apoptotic and necrotic photoreceptor death after retinal
detachment (n =4e a c h ) .Z - V A Dt r e a t m e n ti n c r e a s e dn e c r o t i cc e l l sw h e r e a s
decreased apoptotic cells (P < 0.05 vs. vehicle). Nec-1 plus Z-VAD signi cantly
suppressed the necrotic cell death (P < 0.01 vs. Z-VAD). (Scale bar, 5  m.)
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signi cant increase of carbonyl contents compared with untreated
retina (P < 0.05; Fig. 7A). In contrast, Nec-1 plus Z-VAD
treatment almost completely suppressed the increase of carbonyl
contents after retinal detachment (P < 0.05; Fig. 7A). Rip3
 / 
retinas also showed signi cantly less carbonyl contents after ret-
inal detachment compared with WT retinas (P < 0.01; Fig. 7B).
Apoptosis-inducing factor (AIF) is a caspase-independent in-
ducer of cell death, which is released from the mitochondria and
translocates into the nuclei during cell death (30). We previously
described that mitochondrial release of AIF is a critical event for
the photoreceptor death after retinal detachment (20, 31). Be-
cause ROS overproduction is known to induce mitochondrial
membrane permeabilization and AIF release (32), we next ex-
amined the cellular localization of AIF by immuno uorescence.
AIF translocation into TUNEL-positive photoreceptor nuclei was
increased after retinal detachment; whereas Nec-1 plus Z-VAD
treatment or Rip3 de ciency substantially reduced AIF nuclear
translocation (P < 0.01; Fig. 7 C–F). These data demonstrate that
ROS production and AIF nuclear translocation are downstream
events of RIP signaling.
Discussion
Photoreceptor death after retinal detachment has been thought to
becausedmainly by apoptosis (3,4).Althoughcaspase-dependent
pathwayisknowntobeactivatedafterretinaldetachment,caspase
inhibition by pan-caspase inhibitor fails to prevent photoreceptor
death (18, 20). In this study, we investigated other pathways
leading to photoreceptor death, and demonstrated that necrotic
photoreceptor death occurs after retinal detachment, although its
frequency is approximately half that of apoptosis. Consistent with
our  ndings, Arimura et al. showed that the vitreous level of high-
mobility group box1 protein, which is known to be released from
necrotic cells but not apoptotic cells, is increased in human eyes
with retinal detachment (33, 34). Furthermore, we found that
Z-VAD treatment decreases apoptosis but increases necrotic
photoreceptor death after retinal detachment, and that Nec-1
cotreatment effectively suppresses necrotic photoreceptor death.
These  ndings clearly demonstrate programmed necrosis as an
essential and complementary mechanism of photoreceptor death,
which is further revealed when caspases are inhibited (Fig. 8). In
other retinal degenerative conditions such as inherited retinal
degeneration and light-induced retinal injury, it has been shown
that the photoreceptor death is not prevented by Z-VAD (35–37),
and thus it may be possible that programmed necrosis may un-
derlie the death execution in these diseases as well.
RIP1 is an adaptor kinase that acts downstream of death do-
main receptors and is essential for both cell survival and death
(38). The kinase activity of RIP1 is crucial for programmed ne-
crosis, but dispensable for prosurvival NF- B activation (9, 10,
39). Consistent with these results, Nec-1 inhibited RIP1 phos-
phorylation, which was increased by Z-VAD after retinal de-
tachment, but showed no effect on NF- B p65 phosphorylation
(Fig. S6). RIP1 switches function to a regulator of cell death when
Fig. 6. Effect of RIP pathways on in ammatory response after retinal de-
tachment. (A and B) Immuno uorescence for CD11b (A)a n dq u a n t i  cation
of CD11b-positive macrophage/microglia in WT and Rip3
 /  retina after
retinal detachment. In WT mice, Z-VAD treatment signi cantly increased
in ltration of CD11b-positive cells compared with vehicle treatment (P <
0.05). This increase of CD11b-positive cells was signi cantly suppressed with
Nec-1 plus Z-VAD treatment or Rip3 de ciency (P < 0.01). (Scale bar, 50  m.)
(C and D) ELISA for MCP-1 on day 3 after retinal detachment in retina
treated with vehicle (n =5 ) ,Z - V A D( n =5 ) ,o rN e c - 1p l u sZ - V A D( n =6 )( C) and
in WT and Rip3
 /  retina (n =5e a c h )( D). The retinas without retinal de-
tachment were used as controls. *P < 0.05; **P < 0.01; NS, not signi cant.
Fig. 5. Rip3 de ciency inhibits induction of programmed necrosis and prevents photoreceptor death after retinal detachment. (A)T E Mp h o t o m i c r o g r a p h si n
the ONL on day 3 after retinal detachment in WT and Rip3
 /  retina treated with vehicle, Nec-1, Z-VAD, or Nec-1 plus Z-VAD. In untreated attached retina, the
retinal morphology was similar in WT and Rip3
 /  mice. A, apoptotic cell; N, necrotic cell. (B)Q u a n t i  cation of apoptotic and necrotic photoreceptor death
after retinal detachment (n = 4 each). Rip3 de ciency inhibits the switch to necrotic cell death by Z-VAD treatment and prevents photoreceptor death after
retinal detachment. (Scale bar, 5  m.)
21698 | www.pnas.org/cgi/doi/10.1073/pnas.1009179107 Trichonas et al.it is unubiquitinated and forms a death signaling complex (40,
41). In addition, recent studies revealed that formation of RIP1–
RIP3 complex is a critical step in the RIP1 kinase activation and
induction of programmed necrosis (14–16). After retinal de-
tachment, RIP3 expression increased more than 10-fold and Rip3
de ciency prevented the shift to necrotic photoreceptor death by
Z-VAD, implying that RIP3 is a key regulator of programmed
necrosis after retinal detachment.
TNF-  and Fas-L are potent inducer of programmed necrosis
as well as apoptosis (11). After retinal detachment, TNF-  was
increased in detached retina (Fig. S7 A and B) and treatment with
neutralizing anti–TNF-  antibody suppressed photoreceptor loss
(Fig. S7 C and D), suggesting that TNF-  may contribute to the
induction of apoptosis and programmed necrosis. In addition to
TNF- , Fas-L/Fas pathway is known to be activated and mediate
photoreceptor death after retinal detachment (19, 42), and may
cooperate with TNF-  to activate RIP kinases and promote
programmed necrosis in addition to apoptosis. Thus, RIP kinases
act as common intermediaries for various upstream death signals
and their blockade in addition to caspases is likely necessary for
effective neuroprotection (Fig. S8).
Overproduction of ROS has been implicated in mitochondrial
dysfunctionand programmednecrosis(43, 44). NADPH oxidase1
forms a complex with RIP1 and generates superoxide during
programmednecrosis(29).Alternatively,RIP3activatesmetabolic
enzymessuchasglutamatedehydrogenase1,andtherebyincreases
mitochondrial ROS production (16). Consistent with these
reports, ROS production after retinal detachment was suppressed
by RIP kinase inhibition. In addition, our data show that RIP
kinases act upstream of AIF nuclear translocation. Recent studies
demonstrate that AIF is an essential mediator of programmed
necrosis induced by alkylating DNA damage (45). These results
link RIP kinases, AIF translocation, and programmed necrosis.
Cell death and in ammation communicate with each other dur-
ing neurodegeneration (46). In ltrating in ammatory cells stimu-
lateneuronalcelldeath(28),andconverselydyingcells,especiallyof
the necrotic form, trigger in ammation (47). We previously de-
scribed that MCP-1 is a key mediator of early in ltration of mac-
rophage/microglia after retinal detachment (28). However, MCP-1
up-regulationafterretinaldetachmentwasnotsubstantiallyaltered
by Nec-1 plus Z-VAD or Rip3 de ciency, suggesting that RIP
kinasesarenotinvolvedintheinitiationofin ammation.Ourinsitu
hybridizationdatasuggestthatRIP3isdetectedinONLafterretinal
detachment, suggesting that RIP kinase inhibition may target pho-
toreceptors and suppress in ammation subsequent to photorecep-
tordeath.However,asRIP3isknowntobeexpressedinseveralcell
types including macrophages (48), and given the limited resolution
of our in situ hybridization, we cannot exclude the possibility that
RIP kinase inhibition may affect macrophage/microglia function;
de ning the role of RIP kinases in cell death and in ammation
warrants further studies using tissue-speci c Rip3 knockouts.
Photoreceptor loss occurs acutely after retinal detachment, and
the visual acuity of patients with rhegmatogenous retinal detach-
ment is not always restored after successful reattachment surgery.
In other retinal disorders—including the most and second-most
common causes of blindness in the adults of the western world,
age-related macular degeneration and diabetic retinopathy—
detachment of retinal photoreceptors persists chronically and vi-
sion lossprogresses.Thus,neuroprotectiveagentspreventing pho-
toreceptor loss may open a novel therapeutic approach to the
treatment of these diseases. Unfortunately, most promises of
neuroprotection have not come to clinical fruition, likely because
mostoftheworkonthis eldhasbeenfocusedonmonotherapy.In
this work, we identify RIP-mediated programmed necrosis as an
essential pathway for cell loss, which acts in concert with caspase-
dependentapoptosis.SimultaneousinhibitionofbothRIP1kinase
and caspase pathways with small molecule compounds provides
signi cant protection of photoreceptors after photoreceptor de-
tachment and may be used as a therapeutic strategy for preventing
Fig. 8. Proposed mechanism of photoreceptor loss after retinal de-
tachment. (A) After retinal detachment, photoreceptor death is caused
mainly by apoptosis. (B) Caspase inhibition by Z-VAD decreases apoptosis but
promotes RIP-mediated programmed necrosis. (C) Blockade of both caspases
and RIP kinases is essential for effective prevention of photoreceptor loss.
Fig. 7. RIP kinase inhibition pre-
vents ROS production and AIF
nuclear translocation after retinal
detachment. (A and B)E L I S At o
detect carbonyl contents on day 3
after retinal detachment in retina
treatedwithvehicle,Z-VADorNec-
1p l u sZ - V A D( n=7e a c h )( A)an di n
WT and Rip3
 / retina (n=1 0e a c h )
(B). The retinas without retinal de-
tachment were used as controls
(n =6 –8). Double staining for AIF
and TUNEL (C and E)a n dq u a n -
ti cation of AIF/TUNEL double-
positive photoreceptors (D and F)
on day 3 after retinal detachment
in retina treated with vehicle, Z-
VAD, or Nec-1 plus Z-VAD (n =6
each; C and D)a n di nW Ta n d
Rip3
 / retina (n =5e a c h ;E and F).
IS, inner segment. *P < 0.05; **P <
0.01. (Scale bar, 50  m.)
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ceptor loss.
Materials and Methods
Animals and Reagents. All animal experiments adhered to the statement of
the Association for Research in Vision and Ophthalmology, and protocols
were approved by the Animal Care Committee of the Massachusetts Eye and
Ear In rmary. Adult male Brown Norway rats and WT C57BL/6 mice were
purchased from Charles River. Rip3
 /  mice were provided from D. M. Dixit
(Genentech, South San Francisco, CA) and backcrossed to C57BL/6 mice (48).
Nec-1 was provided by J. Yuan (Harvard Medical School, Boston, MA). Z-VAD
was purchased from Alexis.
Induction of Retinal Detachment, TUNEL, and Evaluation of ONL Thickness
Ratio. Experimental retinal detachment was induced as previously described
(20). TUNEL and quanti cation of TUNEL-positive cells in ONL were per-
formed as previously described (28). The ratio of ONL thickness to the total
retinal thickness was determined by ImageJ software and standardized by
that in the attached retina. Five sections were randomly selected in each eye,
and the central area of detached retina and the midperipheral region of
attached retina were photographed. Then, the ONL thickness ratio was
measured at 10 points in each section by masked observers. The data are
expressed as normalized ONL thickness ratio: [(ONL / neuroretina thickness
in detached retina) / (ONL / neuroretina thickness in attached retina)].
Statistical Analysis. All values were expressed as the mean ± SD. Statistical
differences between two groups were analyzed by Mann–Whitney U test.
Multiple group comparison was performed by ANOVA followed by Tukey–
Kramer adjustments. Differences were considered signi cant at P < 0.05. A
detailed description of methods is provided in SI Materials and Methods.
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SI Materials and Methods
Surgical Induction of Retinal Detachment. Experimental retinal
detachment was induced as previously described (1). Brie y, a 30-
gauge needle was inserted into the subretinal space via an ex-
ternal transscleral transchoroidal approach, and 1% sodium
hyaluronate (Provisc; Alcon) containing vehicle (0.05% DMSO
and 0.8% cyclodextrin in PBS solution), Nec-1 (400  M), and/or
Z-VAD (300  M; Alexis) was gently injected into the subretinal
space to enlarge the retinal detachment.
Immuno uorescence. Immuno uorescence was performed as pre-
viously reported (2). The enucleated eyes were frozen in optimal
cutting temperature compound (Sakura Finetechnical). Five-
micrometer-thick sections were cut, air-dried, and  xed in cold
acetone for 10 min. Rabbit anti-AIF (1:100; Cell Signaling Tech-
nology) and rat anti-CD11b (1:50; BD Biosciences) were used as
primaryantibodiesandincubatedat4°Covernight.Anonimmune
serum was used as a negative control. Alexa Fluor 488-conjugated
goat anti-rabbit IgG and Alexa Fluor 594-conjugated goat anti-rat
IgG (Invitrogen) were used assecondaryantibodies and incubated
at room temperature for 1 h. The specimens were imaged by con-
focal microscopy using a Leica HCX APOL 40  lens.
In Situ Hybridization. Partial sequence of mouse RIP3 gene was
ampli ed by RT-PCR using AGCACAGGACACATCAGTTGG
and CTTGAGGCAGTAGTTCTTGGTG, and cloned into the
pCR-II vector (Invitrogen). Digoxigenin-labeled riboprobe was
hybridized at 61 °C overnight, followed by stringent washes. The
cryosections were then treated with an alkaline phosphatase-
conjugated antidigoxigenin antibody (Roche). Hybridization sig-
nals were visualized with BM purple AP substrate (Roche).
TEM. TEM was performed as previously described (1). More than
200 photoreceptors per eye were photographed and subjected to
quanti cation of cell death modes in a masked fashion. Photo-
receptors showing cellular shrinkage and nuclear condensation
werede nedasapoptoticcells,whereasphotoreceptorsassociated
with cellular and organelle swelling and discontinuities in plasma
and nuclear membrane were de ned as necrotic cells. Electron-
dense granular materials were labeled simply as end-stage cell
death/unclassi ed, because these materials are reported to occur
subsequent to both apoptotic and necrotic cell death (3, 4).
RNA Extraction, RT-PCR, and Quantitative Real-Time PCR. TotalRNA
extraction and reverse transcription were performed as previously
reported (1, 5). A real-time PCR assay was performed with the
Prism 7700 Sequence Detection System (Applied Biosystems).
TaqMangeneexpressionassayswereusedtochecktheexpression
of RIP1 (Rn01757378_m1), RIP3 (Rn00595154_m1), and TNF- 
(Rn99999017_m1). For relative comparison of each gene, we an-
alyzed the Ct value of real-time PCR data with the   Ct method
normalizing by an endogenous control (18S ribosomal RNA).
ELISA. The protein contents in retinal extract were determined
with ELISA kits for protein carbonyls (Cell Biolabs), MCP-1 [rat
MCP-1 (Thermo Scienti c), mouse MCP-1 (R&D Systems)], and
TNF-  [rat TNF-  (Invitrogen), mouse TNF-  (R&D Systems)]
according to manufacturer instructions.
Western Blotting. The vitreous and neural retina, combined, was
collected on day 3 after retinal detachment. Samples were run on
4% to 12% SDS-polyacrylamide gel electrophoresis and trans-
ferred onto PVDF membrane. After blocking with 3% nonfat
dried milk, the membrane was reacted with RIP3 (1:10,000;
Sigma), RIP1 (1:2,000; BD Biosciences), phosphoserine (1:2,000;
Enzo), or anti-phosphorylated NF- B p65 (1:1,000; Cell Signal-
ing Technology) antibody. They were then developed with en-
hanced chemiluminescence. Lane-loading differences were
normalized by  -tubulin (1:1,000; Cell Signaling Technology).
Immunoprecipitation. Equal amount of retinal lysates (1 mg) were
incubated with 1  g anti-RIP1 antibody (BD Biosciences) and 20
 L of protein A/G agarose beads (Thermo Scienti c) at 4 °C
overnight. Beads were washed  ve times with lysis buffer and
Tris-buffered saline solution and the immunopellets were then
subjected to Western blotting.
In Vivo PI Staining. Five microliters of PI (50  g/mL) were injected
into the subretinal space 3 d after retinal detachment. After 2 h,
the eyes were enucleated and 10- m-thick cryosections were cut,
air-dried, and  xed in 100% ethanol. DAPI was used to coun-
terstain the nuclei. The center of the detached retina was pho-
tographed with a  uorescence microscope, and the number of
PI-positive cells in ONL was analyzed by ImageJ software.
Reagents. Goat anti-mouse/rat TNF-  blocking antibody was pur-
chasedfromR&DSystems.Therateyesweresubretinallyinjected
with1%ofsodiumhyaluronatecontaining0.1mg/mLofanti–TNF-
  antibody or control goat antibody. Nec-4 and PCI (IDN6556)
were prepared as described in refs. 6 and 7, respectively.
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Trichonas et al. www.pnas.org/cgi/content/short/1009179107 1o f5Fig. S1. In situ hybridization analysis of RIP3. RIP3 signal was detected in retinal tissue, especially in the ONL, after retinal detachment. The retina from Rip3
 / 
animals was used as negative control. GCL, ganglion cell layer; INL, inner nuclear layer. (Scale bar, 50  m.)
Fig. S2. (A) Immunoprecipitation of RIP1 from retinal lysates. One milligram of retinal lysates was incubated with anti-RIP1 antibody and protein A/G agarose
beads. Extracts before (Pre) and after (Post) immunoprecipitation and the immunopellets (IP) were run on a 4% to 12% SDS/PAGE and blotted with anti-RIP1
antibody. Anti-RIP1 antibody alone was used as negative control. Extracts after immunoprecipitation showed almost complete immunodepletion of RIP1 from
the retinal extract. (B) Phosphorylation of RIP1 after retinal detachment. RIP was immunoprecipitated from lysates of untreated retina and of retina 2 d after
retinal detachment with treatment of vehicle, Nec-1, Z-VAD, or Nec-1 plus Z-VAD, and then assessed for phosphorylation by Western blotting. RIP1 phos-
phorylation was elevated especially in Z-VAD-treated detached retina, and this phosphorylation was inhibited by Nec-1 plus Z-VAD.
Fig. S3. Quanti cation of TUNEL-positive photoreceptors (A) and ONL thickness ratio (B) on day 3 after retinal detachment in rats (n =4 –5). Five microliters of
Nec-1 (2 mM) and/or Z-VAD (3 mM) were injected intravitreally 1 d after retinal detachment induction. Treatment with Nec-1 plus Z-VAD signi cantly de-
creased the number of TUNEL-positive cells and prevented the reduction of ONL thickness ratio after retinal detachment (*P < 0.05; **P < 0.01).
Trichonas et al. www.pnas.org/cgi/content/short/1009179107 2o f5Fig. S4. Quanti cation of TUNEL-positive photoreceptors (A, C,a n dE) and ONL thickness ratio (B, D,a n dF) on day 3 after retinal detachment in rats (n =5 –6).
Nec-4, PCI, and/or Z-VAD were injected subretinally at the indicated doses. Treatment with Nec4 or PCI alone did not show any protective effect (A–D). In
contrast, Nec-4 plus Z-VAD or Nec-4 plus PCI treatment signi cantly suppressed photoreceptor loss after retinal detachment (E and F). **P < 0.01.
Trichonas et al. www.pnas.org/cgi/content/short/1009179107 3o f5Fig. S5. PI staining (A and C) and quanti cation of PI-positive photoreceptors (B and D) on day 3 after retinal detachment in retina treated with vehicle,
Z-VAD, or Nec-1 plus Z-VAD (n =6e a c h ;A and B)a n di nW Ta n dRip3
 /  retina (n =5 –6; C and D); *P < 0.05; **P < 0.01. (Scale bar, 100  m.)
Fig. S6. Western blot analysis for phospho-NF B p65 in control retina without retinal detachment and in retina 3 d after retinal detachment with treatment of
vehicle, Z-VAD, or Nec-1 plus Z-VAD. Lane-loading differences were normalized by the level of  -tubulin.
Trichonas et al. www.pnas.org/cgi/content/short/1009179107 4o f5Fig. S7. (A)Q u a n t i t a t i v er e a l - t i m eP C Ra n a l y s i sf o rT N F -   in control retina without retinal detachment (n = 9) and in retina 3 d after retinal detachment with
treatment of vehicle (n = 9), Z-VAD (n = 8), or Nec-1 plus Z-VAD (n = 9). (B) ELISA for TNF-  in retina without retinal detachment (n = 5) and in retina 3 d after
retinal detachment with treatment of vehicle (n =5 ) ,Z - V A D( n =5 ) ,o rN e c - 1p l u sZ - V A D( n = 6). DAPI staining (C)a n dq u a n t i  cation of ONL thickness ratio (D)
in detached retina treated with anti–TNF-  antibody, control antibody, or ZVAD plus Nec-1 on day 3 after retinal detachment (n =4e a c h ) ;* P < 0.05; **P < 0.01.
Fig. S8. Schematic of RIP signaling pathway. RIP1 mediates prosurvival NF- B activation through polyubiquitination of RIP1 in response to TNF- .W h e nR I P 1i s
unubiquitinated, RIP1 switches function to a regulator of cell death. RIP1 forms a death signaling complex with Fas-associated death domain (FADD) and
caspase-8 after stimulation of death domain receptors, and induces caspase-dependent apoptosis. In conditions in which caspase pathway is blocked, RIP1
kinase is activated in RIP1–RIP3 complex and promotes programmed necrosis. TRAF2, tumor necrosis factor-receptor associated signaling adaptor; TRADD, TNF
receptor-associated death domain; cIAP, cellular inhibitor of apoptosis; CYLD, cylindromatosis.
Trichonas et al. www.pnas.org/cgi/content/short/1009179107 5o f5